These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7554777)
1. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Stevens MJ; Feldman EL; Greene DA Diabet Med; 1995 Jul; 12(7):566-79. PubMed ID: 7554777 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Stevens MJ Diabet Med; 1995 Apr; 12(4):292-5. PubMed ID: 7600740 [TBL] [Abstract][Full Text] [Related]
3. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Cameron NE; Eaton SE; Cotter MA; Tesfaye S Diabetologia; 2001 Nov; 44(11):1973-88. PubMed ID: 11719828 [TBL] [Abstract][Full Text] [Related]
4. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Cameron NE; Cotter MA Diabetes; 1997 Sep; 46 Suppl 2():S31-7. PubMed ID: 9285496 [TBL] [Abstract][Full Text] [Related]
5. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Cameron NE; Cotter MA Diabetes Metab Rev; 1994 Oct; 10(3):189-224. PubMed ID: 7835170 [No Abstract] [Full Text] [Related]
6. How does glucose generate oxidative stress in peripheral nerve? Obrosova IG Int Rev Neurobiol; 2002; 50():3-35. PubMed ID: 12198815 [TBL] [Abstract][Full Text] [Related]
7. Aldose reductase in the etiology of diabetic complications. 3. Neuropathy. Stribling D; Armstrong FM; Perkins CM; Smith JC J Diabet Complications; 1989; 3(3):139-48. PubMed ID: 2528557 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and vascular factors in the pathogenesis of diabetic neuropathy. Ward JD Clin Invest Med; 1995 Aug; 18(4):267-74. PubMed ID: 8549012 [TBL] [Abstract][Full Text] [Related]
15. The role of oxidative stress in diabetic vascular and neural disease. Yorek MA Free Radic Res; 2003 May; 37(5):471-80. PubMed ID: 12797466 [TBL] [Abstract][Full Text] [Related]
16. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Cameron NE; Cotter MA Diabetes Res Clin Pract; 1999 Sep; 45(2-3):137-46. PubMed ID: 10588366 [TBL] [Abstract][Full Text] [Related]
17. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179 [TBL] [Abstract][Full Text] [Related]
18. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. Stevens MJ; Dananberg J; Feldman EL; Lattimer SA; Kamijo M; Thomas TP; Shindo H; Sima AA; Greene DA J Clin Invest; 1994 Aug; 94(2):853-9. PubMed ID: 8040341 [TBL] [Abstract][Full Text] [Related]
19. Update on the pathogenesis of diabetic neuropathy. Obrosova IG Curr Diab Rep; 2003 Dec; 3(6):439-45. PubMed ID: 14611738 [TBL] [Abstract][Full Text] [Related]
20. Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic stroke. Cellek S; Anderson PN; Foxwell NA Diabetes; 2005 Jan; 54(1):212-9. PubMed ID: 15616031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]